Citius Pharmaceuticals shares jumped 22.12% after hours following the commercial launch of its LYMPHIR therapy and a fiscal 2025 business update.
Citius Pharmaceuticals Inc. (NASDAQ:CTXR) shares jumped 22.12% in after-hours trading to $1.27 on Tuesday, following the company’s fiscal year 2025 business update and the commercial launch of its flagship oncology therapy.
Check out the current pric… [2841 chars]
Source: Benzinga | Published: 2025-12-24T06:56:31Z
Credit: Benzinga
